Amphetamine Self-Administration in Light and Moderate Drinkers

Alcoholism: Clinical and Experimental Research

Volumn 35, Issue 3, 2011, Pages 443-453

  Stanley, Matthew D ^a   Poole, Mégan M ^b   Stoops, William W ^a,b   Rush, Craig R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alcohol; D Amphetamine; Drinking Status; Self Administration; Subjective Effects

Indexed keywords

AMPHETAMINE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ARTICLE; CLINICAL ARTICLE; DRINKING BEHAVIOR; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; REINFORCEMENT;

ADOLESCENT; ADULT; ALCOHOL DRINKING; AMPHETAMINE; BEHAVIOR, ADDICTIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; QUESTIONNAIRES; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; YOUNG ADULT;

EID: 79951903661     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2010.01361.x     Document Type: Article

References (57)

1. Abreu ME, Griffiths RR (1996) Drug tasting may confound human drug discrimination studies. Psychopharmacology 125:255-257.
2. Cho AM, Coalson DW, Klock PA, Klafta JM, Marks S, Toledano AY, Apfelbaum JL, Zacny JP (1997) The effects of alcohol history on the reinforcing, subjective and psychomotor effects of nitrous oxide in healthy volunteers. Drug Alcohol Depend 45:63-70.
3. Comer SD, Collins ED, Fischman MW (1997) Choice between money and intranasal heroin in morphine-maintained humans. Behav Pharmacol 8:677-690.
4. Comer SD, Collins ED, MacArthur RB, Fischman MW (1999) Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans. Psychopharmacology 143:327-338.
5. Comer SD, Collins ED, Wilson ST, Donovan MR, Foltin RW, Fischman MW (1998) Effects of an alternative reinforcer on intravenous heroin self-administration by humans. Eur J Pharmacol 345:13-26.
6. D'Aquila PS, Peana AT, Tanda O, Serra G (2002) Different sensitivity to the motor-stimulating effects of amphetamine in Sardinian alcohol-preferring and non-preferring rats. Eur J Pharmacol 435:67-71.
7. de Wit H, Doty P (1994) Preference for ethanol and diazepam in light and moderate social drinkers: a within-subjects study. Psychopharmacology 115:529-538.
8. de Wit H, Pierri J, Johanson CE (1989) Reinforcing and subjective effects of diazepam in nondrug-abusing volunteers. Pharmacol Biochem Behav 33:205-213.
9. Doty P, Kirk JM, Cramblett MJ, de Wit H (1997) Behavioral responses to ethanol in light and moderate social drinkers following naltrexone pretreatment. Drug Alcohol Depend 47:109-116.
10. Evans SM, Griffiths RR, de Wit H (1996) Preference for diazepam, but not buspirone, in moderate drinkers. Psychopharmacology 123:154-163.
11. Evans SM, Levin FR (2004) Differential response to alcohol in light and moderate female social drinkers. Behav Pharmacol 15:167-181.
12. Foltin RW, Fischman MW (1991) Methods for the assessment of abuse liability of psychomotor stimulants and anorectic agents in humans. Br J Addict 86:1633-1640.
13. Haertzen CA, Hill HE, Belleville RE (1963) Development of the Addiction Research Center Inventory (ARCI): selection of items that are sensitive to the effects of various drugs. Psychopharmacologia 4:155-166.
14. Hall KM, Irwin MM, Bowman KA, Frankenberger W, Jewett DC (2005) Illicit use of prescribed stimulant medication among college students. J Am Coll Health 53:167-174.
15. Helmus TC, Tancer M, Johanson CE (2005) Reinforcing effects of diazepam under anxiogenic conditions in individuals with social anxiety. Exp Clin Psychopharmacol 13:348-356.
16. Holdstock L, de Wit H (2001) Individual differences in responses to ethanol and d-amphetamine: a within-subject study. Alcohol Clin Exp Res 25:540-548.
17. Hutchison KE, Wood MD, Swift R (1999) Personality factors moderate subjective and psychophysiological responses to d-amphetamine in humans. Exp Clin Psychopharmacol 7:493-501.
18. Jasinski DR (1977) Assessment of the abuse potentiality of morphine-like drugs (methods used in man), in Handbook of Experimental Pharmocology (Martin WR ed), pp 197-258. Springer-Verlag, Berlin, Germany.
19. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE (2009) Monitoring the Future national survey results on drug use, 1975-2008. Volume I: Secondary School Students. NIH Publication No. 09-7402. National Institute on Drug Abuse, Bethesda, MD.
20. Kelly TH, Delzer TA, Martin CA, Harrington NG, Hays LR, Bardo MT (2009) Performance and subjective effects of diazepam and d-amphetamine in high and low sensation seekers. Behav Pharmacol 20:505-517.
21. Kelly TH, Robbins G, Martin CA, Fillmore MT, Lane SD, Harrington NG, Rush CR (2006) Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status. Psychopharmacology 189:17-25.
22. King AC, Houle T, de Wit H, Holdstock L, Schuster A (2002) Biphasic alcohol response differs in heavy versus light drinkers. Alcohol Clin Exp Res 26:827-835.
23. Kreek MJ, Neilsen DA, Butelman ER, LaForge KS (2005) Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 8:1450-1457.
24. Kroutil LA, Van Brunt DL, Herman-Stahl MA, Heller DC, Bray RM, Penne MA (2006) Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend 84:135-143.
25. Laviola G, Adriani W, Terranova ML, Gerra G (1999) Psychobiological risk factors fo vulnerability to psychostimulants in human adolescents and animal models. Neurosci Biobehav Rev 23:993-1010.
26. Lott DC, Kim SJ, Cook EH, de Wit H (2005) Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology 30:602-609.
27. Manley SJ, Little HJ (1997) Enhancement of amphetamine- and cocaine-induced locomotor activity after chronic ethanol administration. J Pharmacol Exp Ther 281:1330-1339.
28. Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245-258.
29. McCabe SE, Knight JR, Teter CJ, Wechsler H (2005) Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 100:96-106.
30. McCabe SE, Teter CJ, Boyd CJ (2004) The use, misuse and diversion of prescription stimulants among middle and high school students. Subst Use Misuse 39:1095-1116.
31. McKinzie DL, McBride WJ, Murphy JM, Lumeng L, Li TK (2002) Effects of amphetamine on locomotor activity in adults and juvenile alcohol-preferring and -nonpreferring rats. Pharmacol Biochem Behav 71:29-36.
32. Mikkola JA, Honkanen A, Piepponen TP, Kiianmaa K, Ahtee L (2001) Effects of repeated cocaine treatment on striatal dopamine release in alcohol-preferring AA and alcohol-avoiding ANA rats. Naunyn Schmiedebergs Arch Pharmacol 363:209-214.
33. ® Among Full-Time College Students. Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD.
34. Oliveto AH, Bickel WK, Hughes JR, Shea PJ, Higgins ST, Fenwick JW (1992) Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports. J Pharmacol Exp Ther 261:885-894.
35. Poulin C (2007) From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots. Addiction 102:740-751.
36. Rush CR, Baker RW (2001) Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers. Exp Clin Psychopharmacol 9:59-73.
37. Rush CR, Essman WD, Simpson CA, Baker RW (2001) Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans. J Clin Psychopharmacol 21:273-286.
38. Rush CR, Kelly TH, Fillmore MT, Hays LR (2003a) Discriminative-stimulus effects of triazolam in light and moderate drinkers. Alcohol Clin Exp Res 27:638-646.
39. Rush CR, Kollins SH, Pazzaglia PJ (1998) Discriminative-stimulus and participant-rated effects of methylphenidate, buptopion and triazolam in d-amphetamine trained humans. Exp Clin Psychopharmacol 6:32-44.
40. Rush CR, Stoops WW, Hays LR, Glaser PE, Hays LS (2003b) Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. J Pharmacol Exp Ther 306:195-204.
41. Saladin ME, Brady KT, Dansky BS, Kilpatrick DG (1995) Understanding comorbidity between PTSD and substance use disorders: two preliminary investigations. Addict Behav 20:643-655.
42. Sevak RJ, Stoops WW, Glaser PEA, Hays LR, Rush CR (2010) Reinforcing Efects of d-amphetamine: influence of novel ratios on a progressive-ratio schedule. Behav Pharmacol [Epub ahead of print].
43. Stoops WW, Filmore MT, Poonacha MS, Kingery JE, Rush CR (2003a) Alcohol choice and amphetamine effects in light and moderate drinkers. Alcohol Clin Exp Res 27:804-811.
44. Stoops WW, Glaser PEA, Fillmore MT, Rush CR (2004) Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. J Psychopharmacol 18:534-543.
45. Stoops WW, Glaser PEA, Rush CR (2003b) Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate: a dose-response analysis. Drug Alcohol Depend 71:179-186.
46. Stoops WW, Lile JA, Fillmore MT, Glaser PEA, Rush CR (2005a) Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration. Psychopharmacology 177:349-355.
47. Stoops WW, Lile JA, Fillmore MT, Glaser PEA, Rush CR (2005b) Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology 182:186-193.
48. Stoops WW, Lile JA, Robbins GC, Martin CA, Rush CR, Kelly TH (2007a) The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status. Addict Behav 32:1177-1188.
49. Stoops WW, Vansickel AR, Lile JA, Rush CR (2007b) Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans. Pharmacol Biochem Behav 87:20-29.
50. Stromberg MF, Mackler SA (2005) The effect of cocaine on the expression of motor activity and conditioned place preference in high and low alcohol-preferring Wistar rats. Pharmacol Biochem Behav 82:314-319.
51. Substance Abuse and Mental Health Services Administration (2009) Results from the 2008 National Survey on Drug Use and Health: National Findings. NSDUH Series H-36, DHHS Publication No. (SMA) 09-4434. Office of Applied Studies, Rockville, MD.
52. Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ (2006) Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 26:1501-1510.
53. Tirelli E, Laviola G, Adriani W (2003) Ontogenesis of behavioral sensitization and conditioned place preference induced by psychostimulants in laboratory rodents. Neurosci Biobehav Rev 27:163-178.
54. Vansickel AR, Stoops WW, Rush CR (2010) Human sex differences in d-amphetamine self-administration. Addiction 105:727-731.
55. Walker DJ, Zacny JP (2001) Lack of effects of ethanol pretreatment on the abuse liability of nitrous oxide in light and moderate drinkers. Addiction 96:1839-1845.
56. Walsh SL, Donny EC, Nuzzo PA, Umbricht A, Bigelow GE (2010) Cocaine abuse versus cocaine dependence: cocaine self-administration and pharmacodynamic response in the human laboratory. Drug Alcohol Depend 106:28-37.
57. Zacny JP, Walker DJ, Drum M, Sells M (2008) Choice of sevoflurane and its subjective and psychomotor effects in light and moderate drinkers. Drug Alcohol Depend 94:101-108.